%20(2).jpg)
Karen is a founding member and co-leader of the Psychedelics and Emerging Therapies practice group at Husch Blackwell. With over sixteen years of experience in product liability litigation focusing on toxic products, Karen has a unique perspective in the emerging area of psychedelic therapeutics. She keeps current on the academic and commercial research and drug discovery efforts in this rapidly changing field, such as the development of medicines for PTSD and treatment-resistant depression. Karen assists psychedelics clients in navigating and complying with complex regulatory issues and protecting and commercializing intellectual property. She has a particular focus on helping clients forecast and take steps to protect against potential claims for product liability.
Ray, with over 20 years in Silicon Valley's SaaS market, expertly blends traditional leadership with cutting-edge strategies as a distinguished startup executive coach. His vast experience in tech's dynamic landscape establishes a robust foundation for navigating the complexities of innovation with startup leaders. Venturing beyond traditional approaches, Ray enriches leadership development with psychedelic insights, offering a novel viewpoint for CEOs and founders. With 19 years in psychedelic guidance, he skillfully combines age-old practices with modern leadership frameworks, crafting pathways for personal and professional growth.
Kimberly serves as a co-founder and co-leader of Husch Blackwell's Psychedelic and Emerging Therapies practice group. As a former life sciences researcher, Ms. Chew utilizes her ability to understand and explain complex topics to advise clients as to regulatory and legal liability issues. As a dedicated problem solver and advisor on regulatory compliance, Kimberly is passionate about guiding innovators and medical professionals through the complexities of bringing groundbreaking therapies to market. Her work is fueled by a commitment to explore the transformative potential of psychedelic therapeutics in addressing intractable mental health disorders, including PTSD, and she feels privileged to provide legal counsel as these innovative therapies advance through the clinical trial stages.
Cassandra Vieten, PhD is Clinical Professor in the Department of Family Medicine at UC San Diego. She is co-founder and Psychology Director at the UCSD Center for Psychedelic Research, Director of the Center for Mindfulness, and Director of Research at the Arthur C. Clarke Center for Human Imagination. She is a licensed clinical psychologist, mind-body medicine researcher, author, and internationally recognized keynote speaker and workshop leader.
Serena Wu is a partner of Radicle Law LLP, a law firm providing legal and business solutions to diverse clients who are changemakers in their industries. She is passionate about psychedelics and social entrepreneurship. She has advised professionals in the psychedelic space on the legal boundaries of psychedelic assisted therapy, corporate practice of medicine laws, informed consents, risk and liability mitigation, and religious freedom protections. She has also advised on DAOs, NFTs and their related securities issues. A Harvard Law graduate, she is licensed to practice law in CA and NY.
Anusha Kakani is a startup and social impact attorney and Harvard Law School alum, who co-founded Radicle Law on a mission to use law for social good. Her practice focuses on social entrepreneurship and covers diverse industries and a broad range of general corporate and transactional matters, including venture capital financing, strategic transactions, public offerings, corporate governance matters and regulatory compliance. She has counseled on transactions valued at over $50 billion in the aggregate.
Corrine is a global talent acquisition leader, with a track record of success in recruiting & hiring for emerging industries, especially cybersecurity and data science. Her reputation extends to the alternative wellness space, scaling several 'plant-touching' cannabis companies like Lord Jones, CLICK Spray, and MedMen. Her innate understanding of the challenges, opportunities, and potential in psychedelics goes beyond surface level - she formerly interned at several pharmaceutical companies (including Receptos), completed advanced courses in pharmacological chemistry at UCSD and was a founding partner for a topical CBD brand based in California. Her optimistic advocacy for the growth of the psychedelic industry includes passionate ambassadorship to heighten awareness and understanding of the benefits of psychedelics for people from all walks of life.
Jeffery is the founder and CEO of startup IPROTEAN, an ed-tech startup that provides virtual board education for hospitals and health systems. Brought to the psychedelic space through a family health crisis, Jeff began to deeply appreciate what the medicine has to offer to improve personal healing. A nascent advocate for responsibly advancing research in plant medicines, Jeffery offers an honest, real-life perspective on why psychedelics matter.
Kevin Cannella is a MAPS-trained psychedelic psychotherapist who has been using non-ordinary states to help himself and others heal for 15years. His life’s work has been to help people align with their core values and transform. His years of experience working with ketamine as a breakthrough tool for his clients’ healing have shown him the power of psychedelics in the mental health arena. As a certified MDMA-assisted psychotherapist, Kevin looks forward to the near future when that medicine can be used in the mental healthcare space. After 15 years of this type of work, Kevin has recognized the substantial financial obstacle that prevents most people from having access to the help that they need. His intention with Thank You Life is to create a fund that can open up this treatment to the masses.
Cristianna, a visionary entrepreneur, boasts an impressive 11+ years of experience within the health and wellness space. Her dedication to promoting well-being has been the driving force behind her passion for the health and wellness arena. Demonstrating her exceptional skills, Cristianna has successfully transformed medical practices into thriving multi-million-dollar enterprises. Her adeptness in navigating the business landscape has led to remarkable achievements. Not content with conventional pursuits, Cristianna has immersed herself in the captivating world of psychedelics for several years. A firm believer in the transformative potential of psilocybin, she envisions a brighter future for humanity through the profound impact of these substances. Her journey is a testament to her determination, pioneering spirit, and resolute commitment to making a positive impact. Continuously exploring new frontiers in both business and the psychedelic industry, Cristianna remains an influential force, leaving her imprint on the industries she holds dear.
Dr. Lynn Marie Morski is the president of the Psychedelic Medicine Association and host of the Psychedelic Medicine Podcast. She sits on the advisory boards of Psychedelics Today, Cybin, VETS, Inc. (Veterans Exploring Treatment Solutions), the Oxenberg Foundation, and the Ketamine Task Force. Dr. Morski is a Mayo Clinic-trained physician in family medicine and sports medicine, as well as an attorney and former adjunct law professor.
Kaitlin Roberson is the co-founder and CEO of Cacti Therapeutics, a psychedelic-inspired biotech company developing novel chronic pain and trauma therapies. She moved in this direction after working in the humanitarian field with populations disproportionately affected by trauma and without equitable access to quality care. She has an Ed.M from Harvard University in Human Development and Psychology with an emphasis on childhood adversity and trauma care for refugees. In Kait's spare time, she trains for triathlons, boxes, chases 4 kids and 4 pets around, and volunteers with various NGOs. Her passion is mobilizing people to find community-based solutions to our challenges and her dream is that one day access to trauma healing is available to all.
Jeffery is the founder and CEO of startup IPROTEAN, an ed-tech startup that provides virtual board education for hospitals and health systems. The company was founded in '2018 and was acquired last summer. Jeffery is now leading the division with the acquiring company, Veralon, a national healthcare consulting management firm. Jeffery has founded multiple startups here in San Diego, and remains active in the startup community as investor and advisor. He has participated as business judge at dozens of pitch competitions over the years, including competitions at UCSD, San Diego State University, and USD.
Synthetic Biologist, exited biotech entrepreneur, and currently working in finance to help translate the best in deep biotech with financing and advisory services. Brendan was initially hired to diligence the wave of psychedelics companies going public in early 2021 and support financing for those with strong scientific data and commercial potential such as Mindset, Cybin, Bright Minds, and Reunion. He has diligenced in depth the vast majority of companies in the psychedelic space using a self-developed framework for scientific, clinical, regulatory, IP and commercial value. More generally, he has a specialist role at the investment bank Stifel Canada where he conducts technical due diligence, sources opportunities, and provides strategic advisory for companies in any area touching on biotechnology.
With investment experience in stocks, cryptocurrency, and real estate, he takes a human-centric approach to his investing. He primarily focuses on the potential of the people manifesting the projects he invests in. Passionate about personal development, Matthew actively works with his awareness and energy and serves others by sharing techniques to empower them in their lives and careers. Matthew believes psychedelics are extremely powerful tools for healing and personal transformation. He has contributed to projects in the psychedelic and holistic healing spaces and has explored various cultures, healing modalities, and retreat centers around the world. Professionally, Matthew has made contributions to the biotech, energy, and beverage industries. He holds a degree in mechanical engineering from Cal Poly, San Luis Obispo.
Richard Lin is the founder of Explora BioLabs, a leading biotech facility-as-a-service company. After bootstrapping its startup and growing the company to seven facilities entirely by organic growth, he led a successful exit and sold the company to the Seabright Fund led by Sandy Paige in mid-2018. Explora's strong growth and reputation eventually led to its acquisition by Charles River Lab in April 2022 for $295M. Richard is passionate about helping innovative entrepreneurs find their success. He currently serves as a board member or an advisor for several emerging companies, including BioXceed, VisiCell and PhenoVista. Richard is part of the San Diego angel investment community, having participated in several San Diego Angel Conferences (SDAC), and has made several other individual investments.
The future of Biology is Digital and AI stands at the forefront of this transformative journey! We invite you to join us for an enlightening day of discovery, networking, and inspiration, where we delve into the realm of AI-powered Digital Biology and its profound influence on the future of Biotechnology, Pharmaceuticals, and Life itself!
AI Digital Biology is reshaping the life sciences economy through modeling, computational biology, omics data, and synthetic biology. It has the power to not only save lives but also mitigate pollution and maybe expedite the pace of evolution.
Come support startup companies in the AIDBio space. We extend a warm invitation to all biotech, pharma, academics, entrepreneurs, and investors to be a part of the AI Digital Biology Era. Connect with leading AI industry experts, and engage in passionate discussions, sharing your insights and perspectives with our vibrant community.
Are you ready to supercharge your innovative startup in the cutting-edge fields of Artificial Intelligence and Machine Learning? Don't miss this golden opportunity to bring your vision to life!
Pitch your startup to an audience of industry experts, colleagues, and seasoned investors to gain valuable insights and feedback, forge strategic partnerships and connections, secure vital funding for your pioneering project, and elevate your startup to the next level!
